BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22116550)

  • 41. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistence of self-renewing leukemia cell progenitors during remission in children with B-precursor acute lymphoblastic leukemia.
    Estrov Z; Ouspenskaia MV; Felix EA; McClain KL; Lee MS; Harris D; Pinkel DP; Zipf TF
    Leukemia; 1994 Jan; 8(1):46-52. PubMed ID: 8289497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome.
    Norén-Nyström U; Roos G; Bergh A; Botling J; Lönnerholm G; Porwit A; Heyman M; Forestier E
    Leukemia; 2008 Mar; 22(3):504-10. PubMed ID: 18094715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia.
    Guggemos A; Eckert C; Szczepanski T; Hanel C; Taube T; van der Velden VH; Graf-Einsiedel H; Henze G; Seeger K
    Haematologica; 2003 Jul; 88(7):737-46. PubMed ID: 12857551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low expression of
    Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
    Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The abnormal expression of IKZF1 encoded protein-IKAROS in B-ALL children].
    Huang XH; Chen J; Li BS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):743-7. PubMed ID: 24034916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia.
    Uyen TN; Sakashita K; Al-Kzayer LF; Nakazawa Y; Kurata T; Koike K
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27643535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
    Dehghan-Nayeri N; Eshghi P; Pour KG; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):177-185. PubMed ID: 28585036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling.
    Liebig S; Neumann M; Silva P; Ortiz-Tanchez J; Schulze V; Isaakidis K; Schlee C; Schroeder MP; Beder T; Morris LGT; Chan TA; Bastian L; Burmeister T; Schwartz S; Gökbuget N; Mochmann LH; Baldus CD
    Sci Rep; 2023 Jan; 13(1):972. PubMed ID: 36653435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.
    Staal FJ; van der Burg M; Wessels LF; Barendregt BH; Baert MR; van den Burg CM; van Huffel C; Langerak AW; van der Velden VH; Reinders MJ; van Dongen JJ
    Leukemia; 2003 Jul; 17(7):1324-32. PubMed ID: 12835720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD20 and Outcome of Childhood Precursor B-cell Acute Lymphoblastic Leukemia: A Meta-analysis.
    Ou DY; Luo JM; Ou DL
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e138-42. PubMed ID: 25222059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD7 aberrant expression led to a lineage switch at relapsed childhood acute pre-B lymphoblastic leukemia.
    Fallah Azad V; Hedayati Asl AA; Tashvighi M; Niktoreh Mofrad N; Haghighi M; Mehrvar A
    Med Mol Morphol; 2016 Mar; 49(1):53-6. PubMed ID: 26242204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype.
    Castro FV; McGinn OJ; Krishnan S; Marinov G; Li J; Rutkowski AJ; Elkord E; Burt DJ; Holland M; Vaghjiani R; Gallego A; Saha V; Stern PL
    Leukemia; 2012 Jul; 26(7):1487-98. PubMed ID: 22266911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells.
    Barisone GA; Satake N; Lewis C; Duong C; Chen C; Lam KS; Nolta J; Dίaz E
    Blood Cells Mol Dis; 2015 Apr; 54(4):329-35. PubMed ID: 25554682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.
    Kühnl A; Gökbuget N; Kaiser M; Schlee C; Stroux A; Burmeister T; Mochmann LH; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Blood; 2011 Dec; 118(24):6362-7. PubMed ID: 22010100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
    Chow YP; Alias H; Jamal R
    BMC Cancer; 2017 Feb; 17(1):120. PubMed ID: 28183295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics.
    Khan NI; Cisterne A; Devidas M; Shuster J; Hunger SP; Shaw PJ; Bradstock KF; Bendall LJ
    Leuk Lymphoma; 2008 Apr; 49(4):710-8. PubMed ID: 18398738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.